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Heterologous facilitationG-protein activated inwardly rectifying K+ channels (GIRKs) of the heterotetrameric GIRK1/GIRK4 composi-
tion mediate IK+ACh in atrium and are regulated by cAMP dependent protein kinase (PKA). Phosphorylation
of GIRK1/GIRK4 complexes promotes the activation of the channel by the G-protein Gβγ-dimer (“heterolo-
gous facilitation”). Previously we reported that 3 serines/threonines (S/Ts) within the GIRK1 subunit are
phosphorylated by the catalytic subunit of PKA (PKA-cs) in-vitro and are responsible for the acute functional
effects exerted by PKA on the homooligomeric GIRK1F137S (GIRK1⁎) channel. Here we report that
homooligomeric GIRK4WT and GIRK4S143T (GIRK4⁎) channels are clearly regulated by PKA phosphorylation.
Heterooligomeric channels of the GIRK1S385CS401CT407C/GIRK4WT composition, where the GIRK1 subunit is de-
void of PKA mediated phosphorylation, exhibited reduced but still signiﬁcant acute effects (reduction during
agonist application was≈49% compared to GIRK1WT/GIRK4WT). Site directed mutagenesis of truncated cyto-
solic regions of GIRK4 revealed four serines/threonines (S/Ts) that were heavily phosphorylated by PKA-cs in
vitro. Two of them were found to be responsible for the acute effects exerted by PKA in vivo, since the effect of
cAMP injection was reduced by ≈99% in homooligomeric GIRK4⁎T199CS412C channels. Coexpression of
GIRK1WT/GIRK4T199CS412C reduced the acute effect by ≈65%. Only channels of the GIRK1S385CS401CT407C/
GIRK4T199CS412C composition were practically devoid of PKA mediated effects (reduction by ≈97%), indicat-
ing that both subunits contribute to the heterologous facilitation of IK+ACh.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The indirect, inhibitory action of numerous neurotransmitter mole-
cules is mediated by G-protein activated inwardly rectifying potassium
channels (GIRKs). GIRKs are triggered by G-protein coupled receptors
(GPCRs) viaG-proteinα- and βγ-subunits. In electrically excitable tissue
GIRKs contribute to autonomous regulation of the heartbeat, nociception
and hormone secretion [1,2]. In electrically non-excitable tissues other
important roles of GIRKs such as platelet activation [3], insulin secretion
[4] and sperm function [5] have also been unravelled. According to this
outstanding importance, single nucleotide polymorphisms or pathologi-
cal mutations in one of the four human genes encoding GIRK subunit
isoforms are causally related to various diseases, including primary aldo-
steronism and hypertension, alcohol abuse, atrial ﬁbrillation, Andersen &sics, Medical University of Graz,
380 4155.
bmayer).
ustria.
; Austria.
or Rehabilitation; Gröbming,
-NC-ND license.Barter syndromes and congenital hyperinsulinism [6–10]. On the
structural level functional GIRK channels are formed as homo- or
heterotetrameric complexes [11]. The pore-forming tetramer is associat-
ed with G-protein α- and βγ-subunits, GPCRs coupling to different clas-
ses of G-proteins, protein kinases and -phosphatases, regulators of
G-protein signalling, adenylate cyclase and cytoskeletal compounds in
order to form membrane-subdomain localized signalling complexes
with speciﬁc functional properties [12–20]. According to this complex
supramolecular organisation, GIRK channels are not simply regulated
byG-protein subunits alone, but additional regulatory pathwaysmediat-
ed by phosphatitylinositole-4,5-bisphosphate, protein kinases and Na+
ions, also exist [1]. GIRK channels, produced by homooligomeric GIRK2
and heterooligomeric GIRK1/GIRK2 or GIRK1/GIRK4 composition, were
found to be regulated by cAMP dependent protein kinase (PKA; [21]).
In the case of IK+ACh, the atrial GIRK1/GIRK4 complex, PKA phosphoryla-
tion was found to provide an “on-switch” for the activation of IK+ACh by
Gβγ itself, whereas protein phosphatase 2A (PP2A) generated GIRKs
that were insensitive to Gβγ [22]. Our laboratory investigated this
outstanding regulation at the single channel level [23] and later on
succeeded to identify the structural determinant on the GIRK1 subunit
in the form of three serine/threonines (S/Ts) within the cytosolic
carboxyl-terminus (CT; [24,25]). So far, most GIRK complexes studied
1215F. Treiber et al. / Biochimica et Biophysica Acta 1828 (2013) 1214–1221in the context of PKA regulationwere of heterooligomeric nature. There-
fore, the aim of the current study was to investigate whether GIRK4 sub-
units also participate in PKA mediated regulation of GIRK tetrameric
complexes. Here we report that GIRK4 homooligomeric channels are
regulated by PKA phosphorylation, identify two S/Ts within the GIRK4
structure that are responsible for the robust increase in both basal and
agonist induced current and show that the GIRK4 subunit plays a signif-
icant role in the PKA regulation of heterooligomeric GIRK1/GIRK4
complexes.
2. Materials and methods
2.1. Reagents
Glutathione Sepharose 4B was from GE Healthcare Europe GmbH,
Vienna, Austria (27-4574-01). SpCAMPS and RpCAMPS were from
Sigma-Aldrich, St. Louis, MO, USA (A166, A165, respectively). [32P]
ATP[γP] was from GE Healthcare Europe GmbH, Vienna, Austria
(25001748). Catalytic subunit of cAMP dependent protein kinase
(PKA-cs) was purchased from Boehringer Ingelheim GmbH, Ingelheim,
Germany (1529-307). All other reagents used were of reagent grade.
2.2. Solutions (concentrations in mmole.L−1 unless stated otherwise)
Phosphorylation buffer (PhB): HEPES (25), MgCl2 (5), EGTA (5),
Tween-20 (0.05%) bufferedwith NaOH to pH: 7.4. 4× SDS loading buffer:
Tris (400), sucrose (20%w/v), SDS (4%w/v), mercaptoethanole (20% v/v)
titrated with HCl to pH: 6.8. Coomassie staining solution: Coomassie bluecAMP inj.
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Fig. 1. Homooligomeric GIRK4 channels are regulated by PKA. A.: Original current recording
tential was kept constant at −80 mV. Basal current (IHK) was induced by changing from th
(HK). G-protein activation was achieved by perfusion with HK containing 10−5 mole/L acety
PKA 3 pmole cAMP were injected into the cytosol of the oocyte (both insertion and injectio
elicited again in order to demonstrate the increase of currents through GIRK4 complexes. B.:
induced currents through homooligomeric GIRK4S143T complexes. Number of individual ooc
niﬁcant from both RpCAMPS and H2O at the pb0.01 level. C.: Statistical analysis of th
homooligomeric and heterooligomeric GIRK channel complexes. Number of individual oocy
signiﬁcant from zero at the pb0.05 (0.001) level.(0.04‰w/v), methanol (50% v/v), acetic acid (10% v/v). Destain I: meth-
anol (50% v/v), acetic acid (10% v/v). Destain II: methanol (5% v/v), acetic
acid (7% v/v). ND96: NaCl (96), KCl (2), MgCl2 (1), CaCl2 (1), HEPES (5)
buffered with NaOH to pH: 7.4. NDE: same as ND96 but CaCl2 was 1.8
and pyruvate (2.5) and antibiotics (0.1% v/v; from 1000× stock from
Sigma-Aldrich (G-1397)) were added. HK: KCl (96), NaCl (2), MgCl2
(1), CaCl2 (1), HEPES (5) buffered with KOH to pH: 7.4.
2.3. Genetic engineering
Ampliﬁcation of plasmids in bacteria, puriﬁcation, linearization, liga-
tion and site directed mutagenesis (using the DpnI method) were
performed using standard procedures [26]. Plasmids with inserts
encoding the different proteins have been already described: m2R [21],
rGIRK1 & hGIRK4 [27]. cRNA was synthesised according to [28]. Phos-
phorylation deﬁcient mutations of heterooligomeric rGIRK1WTwere pro-
duced using the identical primers as described for the homooligomeric
rGIRK1⁎ construct [25]. The primers used for site directed mutagenesis
of potential S/Ts within the hGIRK4 sequence are listed in supplementary
Table S1. Plasmids for production of recombinant truncated intracellular
regions of hGIRK4 fused to GST were produced according to [25] using
suitable primers are listed in supplementary Table S2. All constructs and
mutations were veriﬁed by sequencing.
2.4. Recombinant protein puriﬁcation
Constructs were transfected into BL-21(RIL) competent cells
(Stratagene, La Jolla, CA, USA). Overexpression and puriﬁcation were69DNKH
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Fig. 2. Phosphorylation of the cytosolic regions of GIRK4 by PKA in-vitro. A.: upper
panel: Autoradiogram showing 32P incorporation of the GIRK4 C- and N-terminal fu-
sion proteins following incubation with PKA-cs and ATP-γ-32P. Lower panel: Coomassie
stain of the electrophoresis gel shown in upper panel. B: Statistical analysis of 32P in-
corporation into N- and C-terminus. The number of individual phosphorylation exper-
iments is shown in parenthesis above each bar. ***: the mean value deviates
statistically signiﬁcant from GST at the pb0.001 level.
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was quantitated by the method of Bradford [30], diluted to a concen-
tration of 1 μg. μL−1, aliquots were shock frozen in liquid N2 and
stored at −70 °C until used.
2.5. In-vitro phosphorylation
In-vitro phosphorylation of recombinant protein was performed as
described [25]. Shortly, 1 μg protein was subjected to phosphorylation
in-vitro by PKA-cs using [32P]ATP[γP] as co-substrate. Subsequently
the protein was submitted to SDS-PAGE [31] on a 12% gel. Gels were
stained with Coomassie blue, dried and scanned densitometrically.
Quantitative autoradiography was performed using the Storm Phos-
phor imager (GE Healthcare Europe GmbH, Vienna, Austria). Incorpo-
rated radioactivity was normalized to the total amount of protein as
detected by Coomassie stain (=relative speciﬁc radioactivity).
2.6. Xenopus laevis oocyte expression
The Xenopus laevis oocyte expression system was used exactly as
described [32]. The amounts of RNA injected per oocyte are given in
parenthesis (in ng per oocyte): m2R (2.5); GIRK1WT (0.01–0.25);
GIRK1S385CS401CT407C (1); GIRK4WT (0.01–2.5); GIRK4⁎ (0.01);
GIRK4⁎S75C (0.01); GIRK4⁎S191C (0.165); GIRK4⁎T199C (0.165);
GIRK4⁎S382C/A/E (0.01–10); GIRK4⁎S412C (1); GIRK4⁎S418A (0.01);
GIRK4⁎T199CS412C (1); GIRK4S75C (0.25); GIRK4T199C (0.165);
GIRK4S412C (0.165) and GIRK4T199CS412C (1).
2.7. Electrophysiology
Oocytes were studied following 3–5 day incubation at 19 °C in NDE.
Superfusion with ND96 and HK (with and w/o 10−5 mole/L acetylcho-
line) was performed at 21 °C while the membrane potential was
set to −80 mV and currents were recorded with the two electrode
voltage clamp technique (TEVC) using agarose cushion electrodes [33]
in connection with the Gene Clamp 500 ampliﬁer (Molecular Devices
Germany GmbH (Biberach an der Riss, Germany)). Cytosolic injections
of cAMP and analogues (30–60 pmole per oocyte) during recording
were performed as described [21]. The acute effect of cAMP injection
was quantitated by normalizing the current increase, induced by
cAMP injection (IACh) to the basal current before cAMP injection was
performed (IHK; see Fig. 1A for illustration). Thus, both in the case
when cAMP was injected in the absence or in the presence of agonist,
the cAMP effect is given by: IcAMPIHK . Current traces were low pass ﬁltered
at 10 Hz and digitized at a sampling rate of 50 Hz using the digidata
1322A interface (Molecular Devices (Germany) GmbH, Biberach an
der Riss, Germany) connected to a MS-Windows compatible computer
using the pClamp9.2 software (Molecular Devices (Germany) GmbH,
Biberach an der Riss, Germany).
2.8. Statistical analysis
Results from given experimental groups were compared for statis-
tical signiﬁcance using ANOVA or Student's t-Test, where appropriate
(Sigma Plot 12.0; Systat Software Inc., San Jose, CA 95110 USA). In
some instances, the calculated average value of current increase in
percent was tested for a signiﬁcant difference from zero by assuming
Gaussian distribution [34].
3. Results
3.1. Homooligomeric GIRK4 channel complexes are regulated by PKA
In order to investigate a potential contribution of the GIRK4
subunit, the homooligomeric mutation S143T [35] was introduced
into the human GIRK4 sequence resulting in the human GIRK4⁎subunit. GIRK4⁎ channels were expressed and studied in the Xenopus
laevis oocyte expression system. Interestingly, cytosolic injections of
cAMP led to a signiﬁcant increase of both agonist induced and basal
current through homooligomeric GIRK4⁎ channels (Fig. 1A). To fur-
ther substantiate PKA catalysed phosphorylation as being responsi-
ble, the non-hydrolysable cAMP analogues SpCAMPS (activatory to
PKA) and RpCAMPS (inhibitory to PKA) were injected. SpCAMPS,
but not RpCAMPS, led to considerable augmentation of agonist in-
duced currents, suggesting that PKA was responsible for the rapid
and substantial effect caused by cAMP injections (Fig. 1B). Comparison
of cAMP effects on GIRK1/GIRK4 complexes of different subunit compo-
sition revealed that both homooligomeric GIRK1⁎ (GIRK1F137S), GIRK4⁎
(GIRK4S143T) and GIRK4WT complexes as well as heterooligomeric
GIRK1WT/GIRK4WT complexes were regulated by cAMP injection
resulting in an increase of agonist as well as basal current (Fig. 1C).
This ﬁnding is in line with previous results on the regulation of
GIRK1/GIRK4 complexes by PKA, but indicates that the GIRK4 subunit
may play an additional, hitherto unrecognized, role.
3.2. Identiﬁcation of the structural determinant on the GIRK4 subunit
Since GIRK4 channels revealed themselves susceptible to regulation
by cAMP, it was of interest to investigate whether the cytosolic regions
of GIRK4 subunits are targets for PKA mediated phosphorylation. Re-
combinant GST fusion proteins with the C- and the N-terminal regions
of GIRK4 were used as substrates for phosphorylation by the catalytic
subunit of PKA (PKA-cs) in-vitro. Both intracellular regions were identi-
ﬁed to be substrates for this enzyme, the C-terminus being phosphory-
lated considerably stronger, when compared to the N-terminus
(Fig. 2). This contrasts previous ﬁndings where exclusively the GIRK1,
but not the GIRK4 subunit, was found to be a substrate for PKA [22]. In
this case, however, the IK+ACh complex was immunoprecipitated from
bovine atrium. Besides species differences, a possible explanation for
the failure to phosphorylate GIRK4 in-vitro could be high intrinsic levels
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nant protein produced and puriﬁed by bacteria in the prevailing study.
In order to more closely localize S/Ts responsible for PKA phosphoryla-
tion in-vitro, the GIRK4 C-terminus was further truncated into 4 smaller
regions and subjected to PKA-cs phosphorylation in-vitro. In contrast to
GIRK1, where the three S/Ts responsible for PKA phosphorylation are
localizedwithin a narrow stretch of nomore than 22 amino acidswithin
the C-terminus [25], phosphorylation sites within GIRK4 were dis-
persed all over the C-terminus, the proximal and distal parts being
more prominently phosphorylatedwhen compared to the intermediate
region (supplementary Figs. S1A). S/Ts within the truncated fusion pro-
teins complying to the PKA consensus sequence R/K-[X]1–2-S/T were
mutated to cysteines (in some cases, when the introduction of artiﬁcial
disulphide bonds was regarded to be a potential problem, the resulting
point mutation was alanine). The mutant constructs were subjected to
phosphorylation in vitro which was compared to the phosphorylation
of the corresponding WT construct. In case the 32P incorporation of a
mutant construct was still considerable, additional S/Ts other than the
consensus were also mutated and the corresponding mutant construct
subjected to phosphorylation, until its in-vitro phosphorylation was
negligible. Finally, based on the effect of mutation of individual S/Ts
within a construct, the relative contribution of each individualmutation
to the phosphorylation of the entire cytosolic region (N–T plus C–T
truncations) was calculated. Finally, four amino acids, T199, S382,
S412 and S4128, contributed most prominently to the phosphorylationof the cytosolic parts of GIRK4 (supplementary Figs. S1B). In order to in-
vestigate whether T199, S382, S412 or S418 plays a functional role in
the heterologous facilitation of GIRK currents by PKA, point mutations
were introduced into the entire GIRK4⁎ sequence and the correspond-
ing homooligomeric channel complex was tested for functional cAMP
regulation. The N-terminal amino acids S75 and S191 (which had
been reported to be essential for PKC regulation [36]) were mutated
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tion as we were unable to record signiﬁcant currents from oocytes
injected with GIRK4⁎S382C(A,E) cRNA. When cRNA encoding a
N-terminal fusion protein of eGFP and GIRK4S143TS382C was injected
into oocytes, no ﬂuorescence could be detected, indicating that muta-
tion of S382 prohibited GIRK4 synthesis (data not shown). Hence we
were unable to study this S382 in further detail. From the remaining
three amino acids, T199 and S412 exhibited profound and signiﬁcant
ad hoc effects on PKA regulation, while mutation S418A had no inﬂu-
ence (see supplementary Figs. S2B). The impact of T199 and S412 on
cAMP regulation was further investigated in the homooligomeric
GIRK4⁎ complex. While single mutation of T199 almost completely
abolished the effect of cAMP injections on agonist induced K+ currents,
a single mutation of S412 also greatly reduced functional effects, when
compared to WT. Hence we conclude that both amino acids contribute.
Accordingly, simultaneous mutation of both amino acids led to
homooligomeric channels that were completely insensitive to PKA
modulation (Fig. 3). Since both T199 and S412 exerted profound and
signiﬁcant ad hoc effects upon PKA regulation, these two amino acids
were mutated in the full-length C-terminal construct and the effect on
in vitro phosphorylation was tested. Individual single mutations of
T199 and S412 reduced the level of 32P incorporation catalysed by
PKA-cs signiﬁcantly and to a similar extent, while simultaneous muta-
tion of the two amino acids abolished phosphorylation of the entire
C–T almost completely (Fig. 4).
3.3. Molecular basis of the regulation of the heterooligomeric IK+ACh
complex by PKA
Since PKA catalyses the phosphorylation of both the GIRK1 and
the GIRK4 subunits and both homooligomeric ion channel complexes
are functionally affected by this enzyme, it was of interest to assess
the role of each subunit type to the heterologous facilitation of the
heterooligomeric IK+ACh complex that plays an essential role in the
regulation of the heartbeat by the autonomous nervous system [37],
but presumably is also important in the central nervous system
[38]. Combinations of wild type and phosphorylation deﬁcient
GIRK1S385S401CT407C and GIRK4T199CS412C subunits were coexpressed
and their regulation by cAMP injections was compared. The impor-
tance of PKA catalysed phosphorylation of both subunits is under-
lined by the fact that incorporation of either the phosphorylation-
deﬁcient GIRK1S385S401CT407C or the GIRK4T199CS412C subunit into the
heterooligomeric complex resulted in a considerable reduction of
cAMP facilitation of currents, but it was still clearly detectable. Only
GIRK1/4 complexes comprising both types of phosphorylation-
deﬁcient subunits were completely devoid of facilitation mediated
by cAMP injection (Fig. 5). Hence we conclude that both subunits
contribute to the heterologous facilitation of G-protein activation by
PKA. At the molecular level ﬁve S/Ts, namely T199 and S412 on the
GIRK4 subunit and S385, S401 and T407 on the GIRK1 subunit are re-
quired to produce the regulatory action.
4. Discussion
The present study provides clear evidence that phosphorylation of
the GIRK4 subunit plays an important role in the regulation of
heterooligomeric GIRK1/GIRK4 channel complexes by PKA. PKA phos-
phorylation exerted robust stimulation of currents mediated by
homooligomeric GIRK4 channels. Threonine-199 and serine-412
were identiﬁed as the structural determinant being responsible for
≈95% of phosphorylation of the cytosolic GIRK4 C-terminus catalysed
by PKA in-vitro and ≈99% of the acute effect exerted by cAMP
injections on homooligomeric GIRK4 channels in-vivo. Within the
heterooligomeric GIRK1/GIRK4 complex, T199 and S412 contribute
to ≈65% to the acute effect induced by PKA when coexpressed with
the GIRK1WT subunit. Acute PKA effects were practically absent(reduction to ≈3% vs. WTs) in heterotetrameric channels composed
of both phosphorylation-deﬁcient GIRK1 and GIRK4 subunits.
Speciﬁcity of S/T protein kinases is determined to a great extent by
3-D structure of the protein substrate and hence is completely under-
stood in selected cases only [39]. In addition to 3-D structure,
1219F. Treiber et al. / Biochimica et Biophysica Acta 1828 (2013) 1214–1221molecular determinants within the primary sequence near the target
S/T exist that favour PKA phosphorylation. All 3 S/Ts that have been
identiﬁed previously within the GIRK1 sequence [25] conform to the
classical PKA consensus sequence –R/K1–2-X-S/T-, that is known to
occur in about 95% of PKA substrates [40]. While T199 within GIRK4
also represents a “classical” PKA consensus sequence, S412 does not.
According to [39] basic residues (R/K) at positions −4 to −7 can
compensate, at least partially, for the lack of arginyl residues at posi-
tions −2 and/or −3 and indeed a K is located at position −5 in the
case of S412. Obviously K407, together with the 3-D structure of the
GIRK4 C-T, renders S412 susceptible to PKA. Noteworthy, the nearby
located S418 conforms to the classical consensus sequence described
above and was phosphorylated by PKA-cs in our in vitro assay to an
extent comparable to S412. Site-directed mutagenesis of S418 re-
vealed, however, that this amino acid was not involved in the acute
PKA effects described here. We conclude that S418 is either not phos-
phorylated by PKA in-vivo for reasons of 3-D structure or its phos-
phorylation is responsible, at least partially, for another hitherto
unrecognized effect mediated by PKA.
Partial 3-D structures are available for GIRK1 [41,42] and GIRK2 [11].
Since the structures do not comprise the ﬂexible distal C-termini where
the determinants within GIRK1 and S412 of GIRK4 are located, it is at
present not possible to understand mechanistically how PKA phosphor-
ylation promotes GIRK activation by Gβγ via these S/Ts. T199, however,
is covered by the crystal structures currently available andwemay spec-
ulate about its mechanistical contribution to heterologous facilitation.
The amino acid corresponding to T199 in GIRK4 is conserved throughout
all four GIRK subunits (see Fig. 6) and lies within the trans membrane-
domain/cytosolic-domain (TMD–CTD) linker that is essential for the
control of GIRK1 andGIRK2 gating byG-proteins. According to the crystal
structure of GIRK2, T204 contributes essentially to the stabilization of the
closed conformation of the G-loop gate via a hydrogen bond with Y78 of
the adjacent GIRK2 subunit. Since both amino acids are conserved be-
tween GIRK2 and GIRK4 (T199 and Y53 in GIRK4), the consequence of
phosphorylation of T199 would be the disruption of Y53/T199TM1
.
.. ..
..
.
1           
hGIRK2  MAKLTESMTN VLEGDS...M DQDVE....S PVAIHQP.KL PKQARDDLP
hGIRK3  ~~~~~~~~~~ ~~~~~~~~~M AQE.N.AAFS P.GQEEP... PR..R....
rGIRK1  ~~~~MSALRR KF.GDDYQVV TTSSSGSGLQ PQG...PGQG PQQ..QLVP
hGIRK4  ~~~~~~~~~~ ~MAGDSRNAM NQDME.IGVT P...WDPKKI PKQARDYVP
        83                                         
hGIRK2  DLKWRFNLLI FVMVYTVTWL FFGMIWWLIA YIRGDMD..H IEDPSWTPC
hGIRK3  DLQWRLSLLF FVLAYALTWL FFGAIWWLIA YGRGDLE..H LEDTAWTPC
rGIRK1  DLKWRWNLFI FILTYTVAWL FMASMWWVIA YTRGDLNKAH VGN..YTPC
hGIRK4  DLKWRFNLLV FTMVYTVTWL FFGFIWWLIA YIRGDLD..H VGDQEWIPC
        180         191     199                            22
hGIRK2  AFMVGCMFVK ISQPKKRAET LVFSTHAVIS MRDGKLCLMF RVGDLRNSH
hGIRK3  AFMVGCMFVK ISQPNKRAAT LVFSSHAVVS LRDGRLCLMF RVGDLRSSH
rGIRK1  AFLIGCMFIK MSQPKKRAET LMFSEHAVIS MRDGKLTLMF RVGNLRNSHM
hGIRK4  AFMVGCMFVK ISQPKKRAET LMFSNNAVIS MRDEKLCLMF RVGDLRNSH
            284                                      321     
hGIRK2  INQQSPFWEI SKAQLPKEEL EIVVILEGMV EATGMTCQAR SSYITSEIL
hGIRK3  IDAASPFWEA SRRALERDDF EIVVILEGMV EATGMTCQAR SSYLVDEVL
rGIRK1  IDAKSPFYDL SQRSMQTEQF EVVVILEGIV ETTGMTCQAR TSYTEDEVL
hGIRK4  INEKSPFWEM SQAQLHQEEF EVVVILEGMV EATGMTCQAR SSYMDTEVL
                           382                               
hGIRK2  .A...SRAE. ......LP.. ..LSWSVSSK LNQHAELETE EEE.KNLEE
hGIRK3  .A...ARLDA H.L..Y.... ....WSIPSR LDEKVE...E EGAGEGAGG
rGIRK1  PAITNSK.ER HNSVECLDGL DDISTKLPSK L.QK..ITGR EDFPKKLLR
hGIRK4  .....KR.EG R.LLQYLPSP PLLGGCAEAG LDAEAE.QNE EDEPKGLGG
rGIRK1  LPPKLQKMAG GPTRMEGNLP AKLRKMNSDR FT
Fig. 6. Primary structure alignment of the four GIRK subunit isoforms at the protein level. S/
ylation in-vitro; italics/bold: major effect on phosphorylation in-vitro, but no functional con
gous facilitation). S/Ts that have been found to be important for heterologous facilitation in t
responsible for PKC regulation is marked in darker grey (both GIRK1 and GIRK4; [36]). Arro
Figs. S1). TM1, TM2 and P denote the trans membrane and the pore helices, respectively.interaction what in turn would destabilize the G-loop gates closed con-
formation and promote its opening in GIRK4 homooligomeric channels.
Protein phosphorylation has been shown to play important roles
in the regulation of GIRK channel function in physiology and patho-
physiology. Several excitatory neurotransmitters, including gluta-
mate, inhibit GIRKs via PTX insensitive G-proteins involving the
PLC/PKC pathway [43,44]. The underlying mechanism has been iden-
tiﬁed as PKC-catalysed phosphorylation of two serines located in the
cytosolic part of the GIRK1 and GIRK4 C-termini [36]. Another in-
stance is the phosphorylation of serine 9 in the cytosolic N-terminus
of GIRK2 via a protein kinase that is at present unknown. Protein
phosphatase 1 mediated dephosphorylation of this serine results in
increased surface localisation of GIRK2 at excitatory synapses and den-
dritic spines and represents an essential mechanism resulting in
depotentiation of long term potentiation (LTP), an important form of
excitatory synapse plasticity [45,46]. Regulation of GIRK1/GIRK4
heterooligomeric channels via PKA is at present well documented al-
though its physiological role remains unidentiﬁed. In the case of atrial
IK+ACh one may speculate that the heterologous facilitation may repre-
sent amechanism for stabilizing themembrane resting potential during
increased speed of conduction and contractility that is required to
prevent re-entry of excitation and ﬁbrillation. Another, pathophysiolog-
ical, function may be indicated by the ß-adrenergic stimulation of
growth of cancer cells that has been shown to be linked to GIRK1 RNA
expression [47]. GIRK1/GIRK4 channels are also known to exist in the
CNS and sparse evidence about possible functional roles, derived from
knockout mice, exists [38]. No data are hitherto available on possible
roles of PKA regulation of GIRK1/GIRK4 channels in the brain.
Homooligomeric GIRK4 channel complexes have been shown to
exist in native atrial tissue [48]. Functional single IK+ACh channels pre-
sumably formed by GIRK4 homooligomers, but with aberrant kinetics
and fast desensitisation, have been observed in atrial myocytes derived
from GIRK1 k.o. mice [49]. Furthermore, Nikolov & Ivanova-Nikolova,
were able to observe atypical small-conductance IK+ACh channels in
atrial myocytes, possibly formed by GIRK4 homooligomers that were2MTP
...
...
..
.
                           57                   75     82 
R HISRDRTK.. ...RK.IQRY VRKDGKCNVH HGNV.RETYR YLTDIFTTLV  
. .....R.... ..GR...QRY VEKDGRCNVQ QGNV.RETYR YLTDLFTTLV  
. .......... ...KKKRQRF VDKNGRCNVQ HGNLGSETSR YLSDLFTTLV  
. .IATDRTRLL AEGKKPRQRY MEKSGKCNVH HGNV.QETYR YLSDLFTTLV  
              179
V TNL.NGFVSA FLFSIETETT IGYGYRVITD KCPEGIILLL IQSVLGSIVN  
V NNL.NGFVAA FLFSIETETT IGYGHRVITD QCPEGIVLLL LQAILGSMVN  
V ANVYN.FPSA FLFFIETEAT IGYGYRYITD KCPEGIILFL FQSILGSIVD  
V ENL.SGFVSA FLFSIETETT IGYGFRVITE KCPEGIILLL VQAILGSIVN  
7                244         255                     277 
I VEASIRAKLI KSKQTSEGEF IPLNQTDINV GYYTGDDRLF LVSPLIISHE  
I VEASIRAKLI RSRQTLEGEF IPLHQTDLSV GFDTGDDRLF LVSPLVISHE  
 VSAQIRCKLL KSRQTPEGEF LPLDQLELDV GFSTGADQLF LVSPLTICHV  
I VEASIRAKLI KSRQTKEGEF IPLNQTDINV GFDTGDDRLF LVSPLIISHE  
      334                                     370 
W GYRFTPVLTL EDGFYEVDYN SFHETYETST PSLSAKELAE L.........  
W GHRFTSVLTL EDGFYEVDYA SFHETFEVPT PSCSARELAE A.........  
W GHRFFPVISL EEGFFKVDYS QFHATFEVPT PPYSVKEQEE MLLMSSPLIA  
W GHRFTPVLTL EKGFYEVDYN TFHDTYETNT PSCCAKELAE M.........  
412            418 
Q ....TER..N .GDVA.NLEN ESKV~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~  
E AGADKEQ..N .GCLP.PPES ESKV~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~  
M SSTTSEKAYS LGDLPMKLQR ISSVPGNSEE KLVSKTTKML SDPMSQSVAD  
S ....REA..R .GSV~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~  
Ts in the GIRK4 sequence are highlighted in grey (italics: no major effect on phosphor-
sequence) or black (both profound effect on phosphorylation in-vitro and on heterolo-
he GIRK1 sequence are also highlighted in black [25]. S191 that has been reported to be
ws indicate the truncations of the C-terminus used for phosphorylation in vitro (suppl.
1220 F. Treiber et al. / Biochimica et Biophysica Acta 1828 (2013) 1214–1221regulated by PKA [50]. Regulation of homooligomeric GIRK4 channels
may represent a potentially important physiological regulation mecha-
nism in atrium but possibly also in other tissues.
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